About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Cleveland | 102 Studies

Clinical Trials Brain CancerCleveland

Brain Cancer Clinical Trials in Cleveland

Find 102 clinical trials for brain cancer near Cleveland, Ohio. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Cleveland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 102 trials

CompletedLerapolturev in Recurrent Malignant GliomaThis is a phase 2 study of lerapolturev, an oncolytic polio/rhinovirus recombinant, in adult patients with recurrent World Health Organization (WHO) grade IV malignant glioma.NCT02986178·San Francisco, California and 5 others CompletedAtrasentan in Treating Patients With Progressive or Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00017264·Birmingham, Alabama and 9 others CompletedA Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade GliomasDrugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00045708·Atlanta, Georgia and 4 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedGossypol in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeThis phase II trial is studying how well gossypol works in treating patients with progressive or recurrent glioblastoma multiforme.NCT00540722·Birmingham, Alabama and 7 others

CompletedLapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade GliomaThis pilot phase I clinical trial studies how well lapatinib ditosylate before surgery works in treating patients with high-grade glioma that has come back after a period of time…NCT02101905·Los Angeles, California and 11 others

CompletedA Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) AmplificationThis study seeks to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide (TMZ) followed by combination of ABT-414 with adjuvant TMZ prolongs…NCT02573324·Phoenix, Arizona and 211 others

CompletedBevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain TumorsThis partially randomized phase II trial with a safety run-in component studies the side effects and how well bevacizumab given with or without trebananib works in treating…NCT01609790·Anchorage, Alaska and 243 others

UnknownErlotinib in Treating Patients With Recurrent or Progressive Glioblastoma MultiformeRATIONALE: Erlotinib may stop the growth of cancer cells by blocking the enzymes necessary for cancer cell growth.NCT00054496·Cleveland, Ohio

CompletedRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Chemotherapy uses different ways to stop tumor cells from dividing so they stop growing or die.NCT00002545·Birmingham, Alabama and 259 others

CompletedStudy of Tesevatinib Monotherapy in Patients With Recurrent GlioblastomaThis is a multicenter, Phase 2 study to assess the activity of tesevatinib in patients with recurrent glioblastoma.NCT02844439·Tucson, Arizona and 10 others

TerminatedA Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511This is a multicenter, open-label, continuation study to allow subjects who have previously received Toca 511 to continue to receive Toca FC and to allow for extended safety…NCT04327011·Los Angeles, California and 10 others

CompletedBrachytherapy in Treating Patients With Recurrent Malignant GliomaRATIONALE: Brachytherapy uses radioactive material to kill cancer cells remaining after surgery.NCT00045474·Birmingham, Alabama and 8 others

TerminatedVaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by SurgeryThis randomized phase II trial studies how well giving vaccine therapy with or without bevacizumab works in treating patients with recurrent glioblastoma multiforme that can be…NCT01814813·Anchorage, Alaska and 416 others

CompletedRadiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00006386·Birmingham, Alabama and 235 others

CompletedBioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesThis is a Phase 1, open-label, multicenter, randomized, 2-stage crossover study consisting of 2 phases: Stage I - Pharmacokinetics (Bioequivalence), with an Extension Stage II -…NCT02223052·Scottsdale, Arizona and 9 others

TerminatedRitonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaRATIONALE: Ritonavir and lopinavir may stop the growth of gliomas by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT01095094·Cleveland, Ohio

TerminatedGamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive GlioblastomaThis phase II trial is studying how well gamma-secretase/Notch signalling pathway inhibitor RO4929097 works in treating patients with recurrent or progressive glioblastoma.NCT01122901·Atlanta, Georgia and 4 others

CompletedBCX-1777 in Treating Patients With Refractory CancerRATIONALE: BCX-1777 may stop the growth of cancer cells by blocking the enzymes necessary for their growth.NCT00073944·Cleveland, Ohio

CompletedCediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaThis phase I trial is studying the side effects and best dose of cediranib maleate when given together with cilengitide in treating patients with progressive or recurrent…NCT00979862·Birmingham, Alabama and 10 others

CompletedTetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade GliomaRATIONALE: Drugs used in chemotherapy, such as tetra-O-methyl nordihydroguaiaretic acid (EM-1421), work in different ways to stop the growth of tumor cells, either by killing the…NCT00404248·Birmingham, Alabama and 8 others

PreviousPage 3 of 6Next

Other Conditions in Cleveland

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia